Literature DB >> 6380307

Glucose counterregulation during prolonged hypoglycemia in normal humans.

G B Bolli, I S Gottesman, P E Cryer, J E Gerich.   

Abstract

To study glucose counterregulation under conditions approximating those of clinical disorders in which hypoglycemia develops gradually and is reversed over a prolonged period, we injected regular insulin subcutaneously, in a dose (0.15 U/kg) selected to produce two- to threefold increases in plasma insulin, in 11 normal human volunteers and measured plasma glucose, insulin, C-peptide, and counterregulatory hormone concentrations as well as rates of glucose production, glucose utilization, and insulin secretion over 12 h. The data suggest that the mechanisms of gradual recovery from prolonged hypoglycemia may differ from those of rapid recovery from short-term hypoglycemia produced by intravenous injection of insulin in that 1) both stimulation of glucose production and limitation of glucose utilization contribute to recovery from prolonged hypoglycemia; 2) increases in glucagon, epinephrine, growth hormone, and cortisol secretion as well as a decrease in insulin secretion may all participate in glucose counterregulation during prolonged hypoglycemia; 3) epinephrine may play a more important role than glucagon during prolonged hypoglycemia. The latter two conclusions are based primarily on the temporal relationships between changes in the rates of glucose turnover and changes in plasma hormone concentrations and should not be considered proved. However, they provide the basis for testable hypotheses concerning the physiology of gradual recovery from prolonged hypoglycemia that can be expected to be relevant to the pathophysiology of clinical hypoglycemia.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6380307     DOI: 10.1152/ajpendo.1984.247.2.E206

Source DB:  PubMed          Journal:  Am J Physiol        ISSN: 0002-9513


  12 in total

Review 1.  Pathophysiology of sympathoadrenal system.

Authors:  R Giorgino
Journal:  J Endocrinol Invest       Date:  1988-12       Impact factor: 4.256

2.  Hepatic glycogen can regulate hypoglycemic counterregulation via a liver-brain axis.

Authors:  Jason J Winnick; Guillaume Kraft; Justin M Gregory; Dale S Edgerton; Phillip Williams; Ian A Hajizadeh; Maahum Z Kamal; Marta Smith; Ben Farmer; Melanie Scott; Doss Neal; E Patrick Donahue; Eric Allen; Alan D Cherrington
Journal:  J Clin Invest       Date:  2016-05-03       Impact factor: 14.808

3.  Optimal control of blood glucose: the diabetic patient or the machine?

Authors:  Larry Brown; Elazer R Edelman
Journal:  Sci Transl Med       Date:  2010-04-14       Impact factor: 17.956

4.  Glucagon and insulin hypoglycaemia.

Authors:  G B Bolli
Journal:  Diabetologia       Date:  1984-10       Impact factor: 10.122

5.  Prolonged hyperglycaemia during infusion of glucose and somatostatin impairs pancreatic A- and B-cell responses to decrements in plasma glucose in normal man: evidence for induction of altered sensitivity to glucose.

Authors:  G Dimitriadis; P Cryer; J Gerich
Journal:  Diabetologia       Date:  1985-02       Impact factor: 10.122

6.  Counterregulatory hormonal responses to hypoglycaemia in type 1 (insulin-dependent) diabetes: evidence for diminished hypothalamic-pituitary hormonal secretion.

Authors:  B M Frier; B M Fisher; C E Gray; G H Beastall
Journal:  Diabetologia       Date:  1988-07       Impact factor: 10.122

7.  Modest decrements in plasma glucose concentration cause early impairment in cognitive function and later activation of glucose counterregulation in the absence of hypoglycemic symptoms in normal man.

Authors:  P De Feo; V Gallai; G Mazzotta; G Crispino; E Torlone; G Perriello; M M Ventura; F Santeusanio; P Brunetti; G B Bolli
Journal:  J Clin Invest       Date:  1988-08       Impact factor: 14.808

8.  Liver glycogen-induced enhancements in hypoglycemic counterregulation require neuroglucopenia.

Authors:  Shana O Warner; Abby M Wadian; Marta Smith; Ben Farmer; Yufei Dai; Nicole Sheanon; Dale S Edgerton; Jason J Winnick
Journal:  Am J Physiol Endocrinol Metab       Date:  2021-03-29       Impact factor: 4.310

9.  Targeting the Pancreatic α-Cell to Prevent Hypoglycemia in Type 1 Diabetes.

Authors:  Julia K Panzer; Alejandro Caicedo
Journal:  Diabetes       Date:  2021-12       Impact factor: 9.461

10.  C-peptide enhances glucagon secretion in response to hyperinsulinemia under euglycemic and hypoglycemic conditions.

Authors:  Mary Courtney Moore; Shana O Warner; Yufei Dai; Nicole Sheanon; Marta Smith; Ben Farmer; Rebecca L Cason; Alan D Cherrington; Jason J Winnick
Journal:  JCI Insight       Date:  2021-06-22
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.